Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
American Journal of Clinical Pathology|September 25, 2020
Biospecimen Collection During the COVID-19 PandemicHeather A Lankes, Hala Makhlouf
Hepatology Communications|February 7, 2018
Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver diseaseZobair M Younossi, Maria Stepanova, Nila Rafiq, et al.
Hepatology (Baltimore, Md.)|March 2, 2011
Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortalityZobair M Younossi, Maria Stepanova, Nila Rafiq, et al.
Digestive Diseases and Sciences|June 19, 2013
Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD)Maria Stepanova, Nila Rafiq, Hala Makhlouf, et al.
Plos One|May 20, 2020
NADPH oxidase 1 is highly expressed in human large and small bowel cancersJiamo Lu, Guojian Jiang, Yongzhong Wu, et al.
The American Journal of Surgical Pathology|March 8, 2017
Biliary Adenofibroma of Liver: Morphology, Tumor Genetics, and Outcomes in 6 CasesThomas Arnason, Darrell R Borger, Christopher Corless, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 25, 2019
IL-4 and IL-17A Cooperatively Promote Hydrogen Peroxide Production, Oxidative DNA Damage, and Upregulation of Dual Oxidase 2 in Human Colon and Pancreatic Cancer CellsYongzhong Wu, Mariam M Konaté, Jiamo Lu, et al.
American Journal of Clinical Pathology|October 16, 2019
Toward Improving Practices for Submission of Diagnostic Tissue Blocks for National Cancer Institute Clinical TrialsHala Makhlouf, Mark A Watson, Heather A Lankes, et al.
Gastroenterology|December 17, 2009
Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infectionJohn McHutchison, Zachary Goodman, Keyur Patel, et al.
Pageof 2